Question · asked by 1 review
Colchicine plus standard care vs placebo or usual care: Quality of life, including fatigue and neurological functioning;
- Population
- individuals with moderate or severe COVID‐19
- Intervention
- Colchicine plus standard care
- Comparison
- placebo or usual care
- Outcome
- Quality of life, including fatigue and neurological functioning;
The review found no eligible studies for this question.
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Colchicine plus standard care vs standard care (plus/minus placebo) Quality of life, including fatigue and neurological status at longest · people with COVID‐19 and moderate to severe disease The review found no eligible studies for this question. Colchicine for the treatment of COVID‐19 (2021) · Cochrane Headline outcomes only | no estimate extracted | Not reported | No studies found |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Colchicine for the treatment of COVID‐19 2021 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.